These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. [Loss of p16 gene in bladder cancer and genitourinary carcinoma cell lines]. Guo D; Gu F; Zhou A Zhonghua Wai Ke Za Zhi; 1996 Nov; 34(11):643-4. PubMed ID: 9590746 [TBL] [Abstract][Full Text] [Related]
34. Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Sun CQ; Arnold R; Fernandez-Golarz C; Parrish AB; Almekinder T; He J; Ho SM; Svoboda P; Pohl J; Marshall FF; Petros JA Cancer Res; 2006 Sep; 66(17):8542-9. PubMed ID: 16951166 [TBL] [Abstract][Full Text] [Related]
35. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154. Loskog A; Tötterman TH; Böhle A; Brandau S Cancer Gene Ther; 2002 Oct; 9(10):846-53. PubMed ID: 12224026 [TBL] [Abstract][Full Text] [Related]
38. [Synchronous triple urogenital cancer (renal cancer, bladder cancer, prostatic cancer): a case report]. Takada T; Honda M; Momohara C; Komori K; Fujioka H Hinyokika Kiyo; 2002 Apr; 48(4):239-42. PubMed ID: 12048939 [TBL] [Abstract][Full Text] [Related]
39. Absence of frameshift mutations in the bax gene in renal cell cancer (RCC) and transitional cell cancer (TCC). Bilim VN; Kawasaki T; Takahashi K; Tomita Y Anticancer Res; 1998; 18(3A):1655-9. PubMed ID: 9673385 [TBL] [Abstract][Full Text] [Related]
40. Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival. Mackey JR; Au HJ; Hugh J; Venner P J Urol; 1998 May; 159(5):1624-9. PubMed ID: 9554367 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]